Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences to consider raising Rs. 300 crores

CRISIL positive on Krishna Institute of Medical Sciences

CRISIL Ratings has revised its outlook on the long term ratings of Krishna Institute Of Medical Sciences Limited (KIMS) to 'Positive' from 'Stable' while reaffirming the ratings at 'CRISIL AA-/CRISIL A1+'

Krishna Institute of Medical Sciences PAT at Rs 89.12 cr for Q1FY22

KIMS Hospitals' brand, has an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute

Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman

KIMS Hospitals posts strong revenue growth but profits slip sharply in FY26

Profit after tax took a sharp hit, falling to Rs. 33 Cr in Q4 FY26, down from Rs. 106 Cr in Q4 FY25 and Rs. 52 Cr in Q3 FY26

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru

The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof

KIMS enters into MoU for strategic clinical collaboration

The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes

KIMS Hospitals launches cutting-edge Neurosciences Institute in Mahadevapura

KIMS enters Kerala with 20-year operations pact for Avitis Super Speciality Hospital in Palakkad

Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later